Original-Research: Scandinavian Astor Group AB (von NuWays AG): Buy
Source: EQS
Classification of
Another deal unlocks opportunities in the Baltics, PT up. Yesterday, Astor announced the acquisition of AMMUNITY and with that the market entry into the Baltics. Astor has yet again pulled off a strong M&A deal by acquiring AMMUNITY for only 4.4x EV/EBITDA. The company is based in agencies in the Baltics. With FY’24 sales of request for ammunition worth Perfect strategic fit and door opener into the Baltics. Next to strong fundamentals, this acquisition looks set to perfectly fit into Astor’s product portfolio. By now serving ammunition (next to drone and radar jammers, composite parts and various other high-tech equipment), it diversifies the revenue mix and gives it a slightly more recurring touch. More importantly, Astor now has a foot in the door at the Baltic Armed Forces/procurement agencies and thus enters the Baltic defence market by potentially up-selling all of Astor’s product portfolio. Also, the other way, Astor can now also offer the Scandinavian Armed Forces/procurement agencies with supply of ammunition from the close neighbor Astor to fund growth investments. The strong demand for ammunition directly creates the need to expand, whose expenses are likely to be financed by the parent company Astor, given that further debt intak at AMMUNITY (200% net debt/equity, based on acquisition value of equity) should not be healthy. In our view, this should also explain the comparably low acquisition multiple, as it does not contain the upcoming growth investments. Against this backdrop, we confirm our BUY recommendation. We now incorporate the recent M&A (100% of Carbonia; 39% of NSG/Cesium, recorded at equity and now 100% of AMMUNITY) in our estimates, as we assume the closings to go through as announced. Therefore, we raise our estimates accordingly and arrive at a new PT of You can download the research here: http://www.more-ir.de/d/32862.pdf For additional information visit our website: https://www.nuways-ag.com/research-feed Contact for questions: Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 ++++++++++ Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++
The EQS Distribution Services include Regulatory Announcements, |
2156164 17.06.2025 CET/CEST